Earth Science Tech, Inc.

ETST ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2018 FY2015 FY2014 FY2013 FY2012
Operating Activities
Net Income $-1.7M $-8.8M $-12.5M $-62.0K $-22.9K
Depreciation & Amortization $23.5K $4.5K — — —
Depreciation — — — — —
Amortization $4.4K — — — —
Stock-Based Compensation $170.8K $8.4M $12.5M — —
Net Cash from Operating Activities $-1.1M $-376.4K $-241.9K $-51.0K $-25.9K
Investing Activities
Capital Expenditures — $69.0K — — —
Business Acquisitions — — — — —
Net Cash from Investing Activities — — — — —
Financing Activities
Dividends Paid — — — — —
Stock Repurchases — — — — —
Net Cash from Financing Activities $966.0K $423.4K $613.8K $44.1K $33.2K
Net Change in Cash — — — — —
Free Cash Flow — $-445.3K — — —
← Newer Page 2 of 2 Older →